RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,603 | +7.5% | 7,922 | +4.9% | 0.00% | 0.0% |
| Q2 2023 | $56,391 | +12.0% | 7,549 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $50,352 | -22.0% | 7,549 | -9.9% | 0.00% | 0.0% |
| Q4 2022 | $64,571 | -27.5% | 8,375 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $89,110 | +30.7% | 8,375 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $68,173 | +23.8% | 8,375 | +8.9% | 0.00% | +50.0% |
| Q1 2022 | $55,053 | -89.5% | 7,689 | -74.8% | 0.00% | -71.4% |
| Q4 2021 | $522,842 | +179.4% | 30,522 | +275.2% | 0.01% | +133.3% |
| Q3 2021 | $187,163 | -23.1% | 8,134 | +22.0% | 0.00% | 0.0% |
| Q2 2021 | $243,346 | – | 6,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |